ampreloxetine
0169
Phase 3 small_molecule active
Quick answer
ampreloxetine for Symptomatic Neurogenic Orthostatic Hypotension is a Phase 3 program (small_molecule) at Theravance Biopharma with 4 ClinicalTrials.gov record(s).
Program details
- Company
- Theravance Biopharma
- Indication
- Symptomatic Neurogenic Orthostatic Hypotension
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active